Microsoft Research Introduces Quine, a Multimodal AI System for Biological Discovery
Key point
Quine combines a multimodal world model with an interactive harness to prioritize therapeutic compounds, validated in collaboration with the Broad Institute.
Details
Microsoft Research has introduced Quine, an experimental AI research system designed to address the complexity of biology by connecting models, scientific tools, literature, and researchers. The system features a multimodal world model that learns shared representations across biological scales—including sequence, structure, function, cellular state, and imaging—alongside an interactive harness that facilitates iterative discovery.
Core Architecture and Approach
Quine operates on the premise that biology cannot be neatly divided into single-domain tasks. By training jointly across diverse modalities, the system uses evidence from one area to inform predictions in another, capturing relationships that isolated specialist models might miss. The goal is not to replace experimentation but to use computation to explore, rank, and prioritize potential experimental paths before committing scarce laboratory resources.
Validation in Cancer Biology
In collaboration with researchers at the Broad Institute of Harvard and MIT, the team applied Quine to pancreatic ductal adenocarcinoma (PDAC). The system predicted and prioritized thousands of compounds based on their potential to shift tumor cells between therapeutically relevant states. Key findings included:
- Efficiency: The process of narrowing the compound search space and validating top candidates took just one weekend, potentially saving months of experimental work.
- Accuracy: Quine’s highest-ranked compounds produced the largest intended shifts from classical to basal cell states in wet-lab assays.
- Novel Insights: The system predicted that several compounds would move cells toward a distinct third phenotype, an observation confirmed in the lab, suggesting a richer cell-state landscape than previously understood.
Access and Future Development
Quine is currently experimental technology intended solely for research, not clinical or medical use. Access is initially limited to the Quine Fellows program, which provides a cohort of scientists with direct access to the system to accelerate their research and provide feedback. Microsoft plans to expand access through products like Microsoft Discovery as the technology matures.
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.